Online inquiry

IVTScrip™ mRNA-Human ARL4C, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK22042MR)

This product GTTS-WK22042MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ARL4C protein. This product can be used in Effector CD8+ memory T (Tem) cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001282431.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 10123
UniProt ID P56559
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARL4C, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK22042MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK12830MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK19465MR IVTScrip™ mRNA-Human ANXA7, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANXA7
GTTS-WK26275MR IVTScrip™ mRNA-Human ARRB1, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARRB1
GTTS-WK19402MR IVTScrip™ mRNA-Human ANKRD16, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD16
GTTS-WK27469MR IVTScrip™ mRNA-Human ARPC4, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARPC4
GTTS-WK13199MR IVTScrip™ mRNA-Human AGGF1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AGGF1
GTTS-WK28647MR IVTScrip™ mRNA-Human ARL6IP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARL6IP1
GTTS-WK15633MR IVTScrip™ mRNA-Human AIM1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AIM1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW